Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A David Rodrigues

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 25, 2015
Setting Clinical Exposure Levels of Concern for Drug-Induced Liver Injury (DILI) Using Mechanistic in vitro AssaysFalgun Shah, Louis Leung, Hugh A Barton, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 10, 2007
Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC-MS/MS analysisMing Yao, Mingshe Zhu, Michael W Sinz, et al.
Analytical Chemistry|June 20, 2020
A Multiplexed HILIC-MS/HRMS Assay for the Assessment of Transporter Inhibition Biomarkers in Phase I Clinical Trials: Isobutyryl-Carnitine as an Organic Cation Transporter (OCT1) BiomarkerLina Luo, Ragu Ramanathan, Lauren Horlbogen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 14, 2002
Implication of P450-metabolite complex formation in the nonlinear pharmacokinetics and metabolic fate of (+/-)-(1'R*,3R*)-3-phenyl-1-[(1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200) in dogsJames L Ferrero, Samuel B Thomas, Kennan C Marsh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 4, 2006
Characterization of the rhesus monkey CYP3A64 enzyme: species comparisons of CYP3A substrate specificity and kinetics using baculovirus-expressed recombinant enzymesBrian Carr, Ryan Norcross, Yulin Fang, et al.
Clinical Pharmacokinetics|January 27, 2007
Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drugHongjian Zhang, Donghui Cui, Bonnie Wang, et al.
Molecular Pharmaceutics|February 14, 2018
Role of Hepatic Organic Anion Transporter 2 in the Pharmacokinetics of R- and S-Warfarin: In Vitro Studies and Mechanistic EvaluationYi-An Bi, Jian Lin, Sumathy Mathialagan, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 9, 2016
Comprehensive evaluation of liver microsomal cytochrome P450 3A (CYP3A) inhibition: comparison of cynomolgus monkey and humanZuzana E Haarhoff, Melissa A Kramer, Tatyana A Zvyaga, et al.
Bioanalysis|May 12, 2018
LC-MS/MS assay for N<sup>1</sup>-methylnicotinamide in humans, an endogenous probe for renal transportersLina Luo, Jared Kay, Jenny Zhang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 6, 2021
Role of Extracellular Vesicle-Derived Biomarkers in Drug Metabolism and DispositionZivile Useckaite, A David Rodrigues, Ashley M Hopkins, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 25, 2015
Setting Clinical Exposure Levels of Concern for Drug-Induced Liver Injury (DILI) Using Mechanistic in vitro AssaysFalgun Shah, Louis Leung, Hugh A Barton, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 10, 2007
Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC-MS/MS analysisMing Yao, Mingshe Zhu, Michael W Sinz, et al.
Analytical Chemistry|June 20, 2020
A Multiplexed HILIC-MS/HRMS Assay for the Assessment of Transporter Inhibition Biomarkers in Phase I Clinical Trials: Isobutyryl-Carnitine as an Organic Cation Transporter (OCT1) BiomarkerLina Luo, Ragu Ramanathan, Lauren Horlbogen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 14, 2002
Implication of P450-metabolite complex formation in the nonlinear pharmacokinetics and metabolic fate of (+/-)-(1'R*,3R*)-3-phenyl-1-[(1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200) in dogsJames L Ferrero, Samuel B Thomas, Kennan C Marsh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 4, 2006
Characterization of the rhesus monkey CYP3A64 enzyme: species comparisons of CYP3A substrate specificity and kinetics using baculovirus-expressed recombinant enzymesBrian Carr, Ryan Norcross, Yulin Fang, et al.
Clinical Pharmacokinetics|January 27, 2007
Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drugHongjian Zhang, Donghui Cui, Bonnie Wang, et al.
Molecular Pharmaceutics|February 14, 2018
Role of Hepatic Organic Anion Transporter 2 in the Pharmacokinetics of R- and S-Warfarin: In Vitro Studies and Mechanistic EvaluationYi-An Bi, Jian Lin, Sumathy Mathialagan, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 9, 2016
Comprehensive evaluation of liver microsomal cytochrome P450 3A (CYP3A) inhibition: comparison of cynomolgus monkey and humanZuzana E Haarhoff, Melissa A Kramer, Tatyana A Zvyaga, et al.
Bioanalysis|May 12, 2018
LC-MS/MS assay for N<sup>1</sup>-methylnicotinamide in humans, an endogenous probe for renal transportersLina Luo, Jared Kay, Jenny Zhang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 6, 2021
Role of Extracellular Vesicle-Derived Biomarkers in Drug Metabolism and DispositionZivile Useckaite, A David Rodrigues, Ashley M Hopkins, et al.
Pageof 14